(Q37279014)

English

Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease

scientific article published on September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease (English)

1 reference

Europe PubMed Central

19 August 2017

1 reference

based on heuristic

inferred from title

Lorelei A. Mucci

2

object named as

Lorelei A Mucci

1 reference

Europe PubMed Central

19 August 2017

author name string

Tadao Kakizoe

1

1 reference

Europe PubMed Central

19 August 2017

Peter C Albertsen

3

1 reference

Europe PubMed Central

19 August 2017

Michael J Droller

4

1 reference

Europe PubMed Central

19 August 2017

publication date

1 September 2008

1 reference

Europe PubMed Central

19 August 2017

Scandinavian Journal of Urology and Nephrology. Supplement

1 reference

Europe PubMed Central

19 August 2017

218

1 reference

Europe PubMed Central

19 August 2017

191-212

1 reference

Europe PubMed Central

19 August 2017

Cancer screening. Degrees of proof and practical application

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Bladder carcinoma as a systemic disease

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Clonal origin of bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Susceptibility of urothelium to neoplastic cellular implantation

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Genetic studies and molecular markers of bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

The treated natural history of high risk superficial bladder cancer: 15-year outcome

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Screening test accuracy studies: how valid are our conclusions? Application to visual inspection methods for cervical screening

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Cancer screening: the importance of outcome measures.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Number needed to screen: development of a statistic for disease screening.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Case-control studies of cancer screening: theory and practice

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50 years of age.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Defining the role of NMP22 in bladder cancer surveillance

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Urine markers for bladder cancer surveillance: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Considerations on the use of diagnostic markers in management of patients with bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

1 reference

https://api.crossref.org/works/10.1080%2F03008880802284936

21 January 2018

Identifiers

10.1080/03008880802284936

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37279014&oldid=2154415781"